menu
Presentation
November 15, 2019

Evaluation of Oncomine IGH BCR Assays

2019 AMP Corporate Workshop
This presentations provides an evaluation of ThermoFisher's Oncomine IGH BCR Assays, including assay design and feasibility run design.

Download to learn more.

Related Services:
Genomics Laboratory Sequencing Capabilities

Global genomic testing services to support drug discovery, precision medicine, and clinical development

Validation of Oncomine™ Immuno-Oncology NGS Assays at Q2 Solutions 

Trends, Outcomes and Results

T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

Read More